Mucosal T Helper 17 and T Regulatory Cell Homeostasis Correlate with Acute Simian Immunodeficiency Virus Viremia and Responsiveness to Antiretroviral Therapy in Macaques

Megan A. O'Connor, Paul V. Munson, Hillary C. Tunggal, Nika Hajari, Thomas B. Lewis, Debra Bratt, Cassie Moats, Jeremy Smedley, Kenneth C. Bagley, James I. Mullins, Deborah H. Fuller

Research output: Contribution to journalArticle

Abstract

Depletion of gut T helper 17 (Th17) cells during HIV infection leads to decreased mucosal integrity and increased disease progression. Conversely, T regulatory (Treg) cells may inhibit antiviral responses or immune activation. In HIV elite controllers, a balanced Th17/Treg ratio is maintained in the blood, suggesting a role for these responses in controlling inflammation and viral replication. HIV-infected individuals exhibit a range in responsiveness to combination antiretroviral therapy (cART). Given the link between the Th17/Treg ratio and HIV disease, we reasoned these responses may play a role in cART responsiveness. In this study, we investigated the relationship between the mucosal Th17/Treg ratio to acute simian immunodeficiency virus (SIV) viremia and the response to cART. Nineteen rhesus macaques were infected with highly pathogenic SIVΔB670 virus and cART was initiated 6 weeks postinfection. Mucosal CD4 T cell subsets were assessed by intracellular cytokine staining in the colon and mesenteric lymph nodes. Higher baseline Th17/Treg ratios corresponded with increased acute SIV viremia. Th17/Treg ratios decreased during acute SIV infection and were not restored during cART, and this corresponded to increased gut immune activation (Ki67 + ), markers of microbial translocation (sCD14), and T cell exhaustion (TIGIT + ). Animals that maintained a more balanced mucosal Th17/Treg ratio at the time of cART initiation exhibited a better virological response to cART and maintained higher peripheral CD4 counts. These results suggest mucosal Th17 and Treg homeostasis influences acute viremia and the response to cART, a result that suggests therapeutic interventions that improve the Th17/Treg ratio before or during cART may improve treatment of HIV.

Original languageEnglish (US)
Pages (from-to)295-305
Number of pages11
JournalAIDS Research and Human Retroviruses
Volume35
Issue number3
DOIs
StatePublished - Mar 1 2019
Externally publishedYes

Fingerprint

Th17 Cells
Simian Immunodeficiency Virus
Viremia
Macaca
Regulatory T-Lymphocytes
Homeostasis
HIV
Therapeutics
T-Lymphocyte Subsets
Virus Diseases
CD4 Lymphocyte Count
Macaca mulatta
HIV Infections
Antiviral Agents
Disease Progression
Colon
Lymph Nodes
Staining and Labeling
Cytokines
Viruses

Keywords

  • antiretroviral therapy
  • mucosal immune responses
  • rhesus macaque
  • simian immunodeficiency virus
  • Th17
  • Treg

ASJC Scopus subject areas

  • Immunology
  • Virology
  • Infectious Diseases

Cite this

Mucosal T Helper 17 and T Regulatory Cell Homeostasis Correlate with Acute Simian Immunodeficiency Virus Viremia and Responsiveness to Antiretroviral Therapy in Macaques. / O'Connor, Megan A.; Munson, Paul V.; Tunggal, Hillary C.; Hajari, Nika; Lewis, Thomas B.; Bratt, Debra; Moats, Cassie; Smedley, Jeremy; Bagley, Kenneth C.; Mullins, James I.; Fuller, Deborah H.

In: AIDS Research and Human Retroviruses, Vol. 35, No. 3, 01.03.2019, p. 295-305.

Research output: Contribution to journalArticle

O'Connor, Megan A. ; Munson, Paul V. ; Tunggal, Hillary C. ; Hajari, Nika ; Lewis, Thomas B. ; Bratt, Debra ; Moats, Cassie ; Smedley, Jeremy ; Bagley, Kenneth C. ; Mullins, James I. ; Fuller, Deborah H. / Mucosal T Helper 17 and T Regulatory Cell Homeostasis Correlate with Acute Simian Immunodeficiency Virus Viremia and Responsiveness to Antiretroviral Therapy in Macaques. In: AIDS Research and Human Retroviruses. 2019 ; Vol. 35, No. 3. pp. 295-305.
@article{76eb8781008047e5a851caac36f3166b,
title = "Mucosal T Helper 17 and T Regulatory Cell Homeostasis Correlate with Acute Simian Immunodeficiency Virus Viremia and Responsiveness to Antiretroviral Therapy in Macaques",
abstract = "Depletion of gut T helper 17 (Th17) cells during HIV infection leads to decreased mucosal integrity and increased disease progression. Conversely, T regulatory (Treg) cells may inhibit antiviral responses or immune activation. In HIV elite controllers, a balanced Th17/Treg ratio is maintained in the blood, suggesting a role for these responses in controlling inflammation and viral replication. HIV-infected individuals exhibit a range in responsiveness to combination antiretroviral therapy (cART). Given the link between the Th17/Treg ratio and HIV disease, we reasoned these responses may play a role in cART responsiveness. In this study, we investigated the relationship between the mucosal Th17/Treg ratio to acute simian immunodeficiency virus (SIV) viremia and the response to cART. Nineteen rhesus macaques were infected with highly pathogenic SIVΔB670 virus and cART was initiated 6 weeks postinfection. Mucosal CD4 T cell subsets were assessed by intracellular cytokine staining in the colon and mesenteric lymph nodes. Higher baseline Th17/Treg ratios corresponded with increased acute SIV viremia. Th17/Treg ratios decreased during acute SIV infection and were not restored during cART, and this corresponded to increased gut immune activation (Ki67 + ), markers of microbial translocation (sCD14), and T cell exhaustion (TIGIT + ). Animals that maintained a more balanced mucosal Th17/Treg ratio at the time of cART initiation exhibited a better virological response to cART and maintained higher peripheral CD4 counts. These results suggest mucosal Th17 and Treg homeostasis influences acute viremia and the response to cART, a result that suggests therapeutic interventions that improve the Th17/Treg ratio before or during cART may improve treatment of HIV.",
keywords = "antiretroviral therapy, mucosal immune responses, rhesus macaque, simian immunodeficiency virus, Th17, Treg",
author = "O'Connor, {Megan A.} and Munson, {Paul V.} and Tunggal, {Hillary C.} and Nika Hajari and Lewis, {Thomas B.} and Debra Bratt and Cassie Moats and Jeremy Smedley and Bagley, {Kenneth C.} and Mullins, {James I.} and Fuller, {Deborah H.}",
year = "2019",
month = "3",
day = "1",
doi = "10.1089/aid.2018.0184",
language = "English (US)",
volume = "35",
pages = "295--305",
journal = "AIDS Research and Human Retroviruses",
issn = "0889-2229",
publisher = "Mary Ann Liebert Inc.",
number = "3",

}

TY - JOUR

T1 - Mucosal T Helper 17 and T Regulatory Cell Homeostasis Correlate with Acute Simian Immunodeficiency Virus Viremia and Responsiveness to Antiretroviral Therapy in Macaques

AU - O'Connor, Megan A.

AU - Munson, Paul V.

AU - Tunggal, Hillary C.

AU - Hajari, Nika

AU - Lewis, Thomas B.

AU - Bratt, Debra

AU - Moats, Cassie

AU - Smedley, Jeremy

AU - Bagley, Kenneth C.

AU - Mullins, James I.

AU - Fuller, Deborah H.

PY - 2019/3/1

Y1 - 2019/3/1

N2 - Depletion of gut T helper 17 (Th17) cells during HIV infection leads to decreased mucosal integrity and increased disease progression. Conversely, T regulatory (Treg) cells may inhibit antiviral responses or immune activation. In HIV elite controllers, a balanced Th17/Treg ratio is maintained in the blood, suggesting a role for these responses in controlling inflammation and viral replication. HIV-infected individuals exhibit a range in responsiveness to combination antiretroviral therapy (cART). Given the link between the Th17/Treg ratio and HIV disease, we reasoned these responses may play a role in cART responsiveness. In this study, we investigated the relationship between the mucosal Th17/Treg ratio to acute simian immunodeficiency virus (SIV) viremia and the response to cART. Nineteen rhesus macaques were infected with highly pathogenic SIVΔB670 virus and cART was initiated 6 weeks postinfection. Mucosal CD4 T cell subsets were assessed by intracellular cytokine staining in the colon and mesenteric lymph nodes. Higher baseline Th17/Treg ratios corresponded with increased acute SIV viremia. Th17/Treg ratios decreased during acute SIV infection and were not restored during cART, and this corresponded to increased gut immune activation (Ki67 + ), markers of microbial translocation (sCD14), and T cell exhaustion (TIGIT + ). Animals that maintained a more balanced mucosal Th17/Treg ratio at the time of cART initiation exhibited a better virological response to cART and maintained higher peripheral CD4 counts. These results suggest mucosal Th17 and Treg homeostasis influences acute viremia and the response to cART, a result that suggests therapeutic interventions that improve the Th17/Treg ratio before or during cART may improve treatment of HIV.

AB - Depletion of gut T helper 17 (Th17) cells during HIV infection leads to decreased mucosal integrity and increased disease progression. Conversely, T regulatory (Treg) cells may inhibit antiviral responses or immune activation. In HIV elite controllers, a balanced Th17/Treg ratio is maintained in the blood, suggesting a role for these responses in controlling inflammation and viral replication. HIV-infected individuals exhibit a range in responsiveness to combination antiretroviral therapy (cART). Given the link between the Th17/Treg ratio and HIV disease, we reasoned these responses may play a role in cART responsiveness. In this study, we investigated the relationship between the mucosal Th17/Treg ratio to acute simian immunodeficiency virus (SIV) viremia and the response to cART. Nineteen rhesus macaques were infected with highly pathogenic SIVΔB670 virus and cART was initiated 6 weeks postinfection. Mucosal CD4 T cell subsets were assessed by intracellular cytokine staining in the colon and mesenteric lymph nodes. Higher baseline Th17/Treg ratios corresponded with increased acute SIV viremia. Th17/Treg ratios decreased during acute SIV infection and were not restored during cART, and this corresponded to increased gut immune activation (Ki67 + ), markers of microbial translocation (sCD14), and T cell exhaustion (TIGIT + ). Animals that maintained a more balanced mucosal Th17/Treg ratio at the time of cART initiation exhibited a better virological response to cART and maintained higher peripheral CD4 counts. These results suggest mucosal Th17 and Treg homeostasis influences acute viremia and the response to cART, a result that suggests therapeutic interventions that improve the Th17/Treg ratio before or during cART may improve treatment of HIV.

KW - antiretroviral therapy

KW - mucosal immune responses

KW - rhesus macaque

KW - simian immunodeficiency virus

KW - Th17

KW - Treg

UR - http://www.scopus.com/inward/record.url?scp=85062404171&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85062404171&partnerID=8YFLogxK

U2 - 10.1089/aid.2018.0184

DO - 10.1089/aid.2018.0184

M3 - Article

C2 - 30398361

AN - SCOPUS:85062404171

VL - 35

SP - 295

EP - 305

JO - AIDS Research and Human Retroviruses

JF - AIDS Research and Human Retroviruses

SN - 0889-2229

IS - 3

ER -